Globe Life Inc stock: Undervalued insurance play worth watching now
Globe Life Inc. is presented as an undervalued insurance company specializing in life and supplemental health products for underserved U.S. demographics. The article highlights its resilient business model, consistent earnings, and status as a stable, dividend-paying stock with low volatility, making it an attractive option for long-term, value-oriented investors seeking defensive growth. Despite some risks like debt levels and insider selling, analysts maintain a "Moderate Buy" rating, pointing to its fair value discount and steady performance.
Four Corners Property Trust Stock Quote, Share Price, News and Analysis
This article provides a comprehensive overview of Four Corners Property Trust (FCPT.US), a real estate investment trust specializing in restaurant and retail properties. It includes market performance data, financial scores, and a breakdown of institutional ownership. Recent news regarding new term loan facilities and board appointments are also highlighted.
Morgan Stanley Lowers The Hanover Insurance Group (NYSE:THG) Price Target to $190.00
Morgan Stanley has lowered its price target for The Hanover Insurance Group (NYSE:THG) from $194 to $190, maintaining an "equal weight" rating. Despite this, the consensus among analysts is a "Moderate Buy" with an average price target of $199.50. The article also notes recent insider selling by executives and significant institutional ownership in the company.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Globe Life Inc. (GL) and Encourages Shareholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has announced an investigation into potential corporate wrongdoing by Globe Life Inc. (GL) and its officers and directors. The firm is encouraging shareholders who purchased Globe Life securities before May 8, 2019, and still hold them, to join the investigation. Bronstein, Gewirtz & Grossman, LLC represents investors in class actions on a contingency fee basis, aiming to recover investor capital and ensure corporate accountability.
CNA Financials: Revenue Breakdown, Margins & Competitor Comparison
The article provides a financial overview of CNA Financial Corp (CNA), detailing its revenue breakdown, profitability margins, and a comparison with its competitors. CNA's revenue is primarily driven by its Commercial segment, and the company exhibits an operating margin of 10.82% and a net margin of 7.89%. It also highlights CNA's market capitalization and its position within the Property & Casualty Insurance industry against rivals like UNM and GL.
Piper Sandler Reaffirms Their Buy Rating on Globe Life (GL)
Piper Sandler analyst John Barnidge has reiterated a Buy rating on Globe Life (GL) with a price target of $167.00. The analyst has a 6.5% average return and 55.97% success rate on recommended stocks. Globe Life reported strong financial results for the last quarter, with revenue of $1.52 billion and net profit of $266 million, though corporate insider sentiment appears negative due to recent share sales.
Globe Life Inc. (GL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of investors who purchased Globe Life Inc. securities before May 8, 2019, and continue to hold them. The investigation focuses on whether Globe Life and its officers engaged in corporate wrongdoing. Investors are encouraged to contact the law firm to assist with the investigation.
Globe Life Inc. stock outperforms competitors on strong trading day
Globe Life Inc. (GL) shares rose 1.78% to $142.60 on Thursday, marking its fourth consecutive day of gains. This performance occurred during a mixed trading session where the S&P 500 Index increased by 0.11% and the Dow Jones Industrial Average fell by 0.13%. The stock's rally indicates outperformance relative to the broader market.
Globe Life's Dividend Hike: Price Drop or Recovery Play?
Globe Life has announced a $0.33 per share quarterly cash dividend, with the ex-dividend date set for April 2, 2026. This move is supported by the company's strong financials, including $5.45 billion in total revenue and $971 million in net income. The article suggests that while the stock price may temporarily dip on the ex-dividend date, Globe Life's history of quick recovery makes it potentially attractive for both short-term dividend capture and long-term investors.
7.5% Yield To Maturity From Globe Life Stock's Baby Bond (NYSE:GL)
This article highlights Globe Life Inc.'s (GL) strong financial position, supported by $30.8 billion in assets and investment-grade credit ratings. It details the attractiveness of GL.PR.D baby bond, which offers a 7.47% yield to maturity and trades below par, outperforming its peers. The bond benefits from Globe Life's 36-year record of uninterrupted dividends and 20 consecutive years of dividend increases, suggesting potential for capital appreciation due to market re-pricing.
Empery Digital, Genius Group sell off BTC as debt comes due for Strategy copycats
Several public companies, including Empery Digital and Genius Group, have sold off significant portions or all of their Bitcoin holdings to manage debt obligations, a trend reflecting the strain on corporate Bitcoin treasury models as BTC's price declined from over $110,000 to below $70,000. While many firms are retreating from accumulation, companies like Strategy, Metaplanet, and American Bitcoin Corp continue to actively buy Bitcoin, indicating a concentration of accumulation among a few key players. The article highlights the structural fragility of debt-funded Bitcoin acquisition strategies in a volatile market.
Zacks.com spotlights Ross Stores, Broadcom, Corning, and Constellation as key highlights
Amid market caution due to rising oil prices and the Iran-Israel conflict, Zacks.com highlights five high-ROE stocks: Ross Stores (ROST), Globe Life Inc. (GL), Broadcom Inc. (AVGO), Corning Inc. (GLW), and Constellation Brands (STZ). The article explains the importance of Return on Equity (ROE) as a metric for identifying companies effectively reinvesting profits and provides a brief overview of each featured company, citing their financial projections and Zacks Ranks.
AXS vs. PLMR: Which P&C Insurance Stock Should You Buy Now?
This article compares two P&C insurance stocks, Axis Capital Holdings Limited (AXS) and Palomar Holdings, Inc. (PLMR), both currently carrying a Zacks Rank #2 (Buy). While the P&C insurance industry faces challenges like catastrophic events, it benefits from improved pricing, digitalization, and a rising rate environment. The analysis concludes that Palomar Holdings appears better positioned due to superior return on equity, net margin, growth projections, and revenue estimates, despite AXS being cheaper in terms of valuation and having seen better price performance.
Zacks.com featured highlights include Ross Stores, Broadcom, Corning and Constellation
This article highlights five stocks with high Return on Equity (ROE) that investors might consider amid market uncertainties, particularly referencing an ongoing Iran-Israel conflict. The selected companies—Ross Stores, Globe Life, Broadcom, Corning, and Constellation Brands—are presented as "cash cow" stocks that efficiently reinvest for high returns, a key factor for solid investment. The article provides a brief profile of each company, including their market position, financial performance indicators, and Zacks Rank.
Bronstein, Gewirtz & Grossman, LLC Encourages Globe Life Inc. (GL) Shareholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Globe Life Inc. (NYSE:GL) shareholders who purchased securities prior to May 8, 2019, and still hold them. The investigation focuses on whether the company and its officers engaged in corporate wrongdoing. The firm encourages affected investors to contact them to assist with the investigation, noting they operate on a contingency fee basis.
Zacks.com featured highlights include Ross Stores, Broadcom, Corning and Constellation
Amid market uncertainty caused by rising oil prices and geopolitical tensions related to an Iran-Israel conflict, Zacks Investment Research highlights five "cash cow" stocks with high Returns on Equity (ROE) as strong investment options. The article identifies Ross Stores, Inc. (ROST), Globe Life Inc. (GL), Broadcom Inc. (AVGO), Corning Inc. (GLW), and Constellation Brands, Inc. (STZ) as companies that effectively reinvest cash for higher returns, making them attractive to investors seeking profitable and efficient businesses. The ROE metric helps investors identify companies with strong financial health and efficient management.
Globe Life EVP Zorn sells $1.2m in stock after option exercise
Rebecca E. Zorn, EVP & Chief Talent Officer of Globe Life Inc., sold $1.2 million worth of company stock on March 31, 2026, after exercising options to acquire shares. This transaction follows the company's recent fourth-quarter 2025 earnings report, which missed EPS and revenue expectations, despite a dividend increase and board expansion. Texas Capital Securities initiated coverage with a buy rating and a $170 price target.
Globe Life EVP Zorn sells $1.2m in stock after option exercise
Rebecca E. Zorn, EVP & Chief Talent Officer of Globe Life Inc. (NYSE:GL), sold over $1.2 million in company stock on March 31, 2026, after exercising options to acquire 8,800 shares. The sales were conducted in multiple transactions at prices ranging from $135.6593 to $137.4038 per share. This transaction follows recent news of Globe Life's Q4 2025 earnings, a dividend increase, expansion of its board, and new analyst coverage with a "buy" rating.
Globe Life EVP Zorn sells $1.2m in stock after option exercise
Globe Life Inc.'s EVP & Chief Talent Officer, Rebecca E. Zorn, sold over $1.2 million in company stock on March 31, 2026, after exercising options to acquire 8,800 shares. This follows recent news of Globe Life reporting Q4 2025 earnings that missed expectations and expanding its board, while Texas Capital Securities initiated coverage with a buy rating.
[Form 4] GLOBE LIFE INC. Insider Trading Activity
Rebecca E. Zorn, EVP & Chief Talent Officer at GLOBE LIFE INC. (GL), exercised 8,800 employee stock options at $98.32 per share and subsequently sold all 8,800 acquired common shares in open-market transactions. The sales occurred at prices ranging from approximately $135.23 to $137.88 per share. Following these transactions, Zorn directly holds 17,797.0997 Globe Life common shares.
Globe Life EVP & Chief Talent Officer Sold Shares Worth Over $1.2M
Rebecca E. Zorn, Globe Life's EVP & Chief Talent Officer, sold a total of 8,800 shares of company common stock on March 31, 2026. The sales, executed at an average price of $136.63 per share, amounted to over $1.2 million. Following these transactions, Zorn directly owns 17,797 shares.
[144] GLOBE LIFE INC. SEC Filing
This article details a Form 144 SEC filing by GLOBE LIFE INC. (GL) on March 31, 2026. The filing indicates a notice of proposed sale of 12,000 shares of common stock resulting from a stock option exercise, with an aggregate market value of $1,637,400. The shares are to be sold through APEX CLEARING on the NYSE.
Globe Life Inc. stock rises Tuesday, still underperforms market
Shares of Globe Life Inc. (GL) rose 1.99% to $139.17 on Tuesday, marking its second consecutive day of gains. Despite this rise, the stock underperformed the broader market, as the S&P 500 Index increased by 2.91% and the Dow Jones Industrial Average gained 2.49%.
5 Stocks With High ROE to Buy as Iran War Crisis Refuses to Abate
Amid geopolitical tensions and rising oil prices, this article suggests that investors consider "cash cow" stocks with high return on equity (ROE) for stable returns. It identifies five companies—Ross Stores (ROST), Globe Life (GL), Broadcom (AVGO), Corning (GLW), and Constellation Brands (STZ)—that meet specific financial screening criteria including high cash flow, strong ROE, and favorable Zacks Ranks. The article highlights these companies' financial health and efficiency in generating profits for shareholders.
Mn Services Vermogensbeheer B.V. Grows Stock Holdings in Duke Energy Corporation $DUK
Mn Services Vermogensbeheer B.V. increased its stake in Duke Energy Corporation by 3.2% in the fourth quarter, bringing its total holdings to 303,306 shares valued at $35.55 million. Other institutional investors like Vanguard Group Inc. and Northern Trust Corp also adjusted their positions in Duke Energy. The article also provides details on Duke Energy's price performance, recent earnings, dividend announcement, and analyst ratings, noting both positive sentiment on its regulated assets and defensive qualities, as well as negative sentiment around potential rate hike pushback.
Texas Capital initiates Globe Life (GL) with buy rating and $170 price target
Texas Capital has initiated coverage on Globe Life (GL) with a Buy rating and set a price target of $170. This new rating suggests a positive outlook for the company's stock from Texas Capital.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Globe Life Inc. (GL) And Encourages Shareholders to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Globe Life Inc. (NYSE:GL) for corporate wrongdoing. The firm encourages shareholders who purchased Globe Life securities before May 8, 2019, and still hold them, to connect with their investigation. Bronstein, Gewirtz & Grossman, LLC represents investors on a contingency fee basis and seeks to recover investor capital.
SG Americas Securities LLC Purchases 89,866 Shares of Globe Life Inc. $GL
SG Americas Securities LLC significantly increased its stake in Globe Life Inc. by 909.6% in Q4, acquiring 89,866 shares to hold a total of 99,746 shares valued at $13.95 million. Globe Life reported Q4 earnings of $3.39 EPS, missing consensus, but saw revenue up 3.6% year-over-year and set optimistic FY2026 guidance. The company also raised its quarterly dividend to $0.33, implying a 1.0% yield.
GL (Globe Life) Loans Receivable
The article discusses Globe Life Inc.'s (NYSE: GL) Loans Receivable feature, noting that it does not apply to banks and insurance companies. GuruFocus assesses GL as "Fairly Valued," with its current stock price of $136.95 trading 6.2% below its estimated GF Value™ of $146.02, and highlights an 89 GF Score with 5 warning signs. It provides a business description for Globe Life Inc., an insurance holding company, and encourages users to access full analysis with a Premium Membership.
Texas Capital Initiates Globe Life (GL) With Buy Rating and $170 Price Target
Texas Capital has initiated coverage on Globe Life Inc. (GL) with a Buy rating and a $170 price target, citing attractive valuation and continued growth in its life and health distribution franchise. This follows Wells Fargo's recent adjustment of its price target to $171 with an Overweight rating. Analysts surveyed by CNN show a consensus Buy view and a one-year median price target of $171 for the company, which primarily serves middle-income families with life and supplemental health insurance.
Texas Capital initiates Globe Life (GL) with buy rating and $170 price target
Texas Capital has initiated coverage on Globe Life (GL) with a Buy rating. The financial firm has set a price target of $170 for the company's stock, indicating a positive outlook for its performance. This initiation suggests Texas Capital's confidence in Globe Life's future prospects.
Texas Capital Initiates Globe Life (GL) With Buy Rating and $170 Price Target
Texas Capital has initiated coverage on Globe Life Inc. (NYSE: GL) with a Buy rating and a $170 price target, citing attractive valuation and continued growth in its life and health distribution franchise. This follows Wells Fargo's recent increase in its price target for GL to $171, maintaining an Overweight rating. Analysts surveyed by CNN show a consensus Buy view, with a 1-year median price target of $171 for the insurance provider.
Texas Capital Initiates Globe Life (GL) With Buy Rating and $170 Price Target
Texas Capital has initiated coverage on Globe Life (GL) with a Buy rating and a $170 price target, citing the company's attractive valuation and continued growth in its life and health distribution franchise. This follows Wells Fargo's recent adjustment of its price target for GL to $171, maintaining an Overweight rating. Globe Life, a provider of life and supplemental health insurance headquartered in Texas, has a consensus Buy rating among 15 analysts with a median 1-year price target of $171.
Manulife shareholders can vote ahead of May 14 annual meeting
Manulife has released its 2026 Management Information Circular and 2025 Annual Report for shareholders, outlining details for its upcoming annual meeting on May 14, 2026, at 11:00 a.m. ET. Shareholders can access these documents online and are encouraged to vote their shares and submit proxies in advance. The circular includes information on director elections and the appointment of auditors.
15 Set-It-and-Forget-It Stocks to Buy in 2026
This article identifies Jack Henry & Associates, Inc. (NASDAQ:JKHY) as one of 15 set-it-and-forget-it stocks for 2026. The company recently strengthened its 15-year partnership with the ICBA by integrating its AI-powered Financial Crimes Defender™ platform. Wells Fargo also upgraded JKHY's rating to Overweight, increasing its price target and adding it to its "Fab 5 of Fintech" list due to anticipated revenue growth acceleration.
Globe Life Inc. stock underperforms Friday when compared to competitors
Globe Life Inc. (GL) saw its stock decline by 2.66% on Friday, closing at $135.11, while the broader market indices like the S&P 500 and Dow Jones Industrial Average also fell. The company's stock is now 11.53% below its 52-week high of $152.71, which it reached on February 5th. This performance indicates that Globe Life Inc. underperformed its competitors amidst a generally negative trading session.
Globe Life Surpasses 200-Day SMA: Is Now the Right Moment to Invest?
Globe Life Inc. (GL) is showing bullish momentum, trading above its 200-day simple moving average and offering attractive valuation compared to industry averages. The company projects strong growth in earnings and revenue for 2026 and 2027, with analysts suggesting a significant upside. Globe Life also demonstrates robust returns on capital, driven by increased premiums, investment income, and effective capital management.
Globe Life Trades Above 200-Day SMA: Time to Buy the Stock?
Globe Life (GL) shares are trading above their 200-day simple moving average, indicating a bullish short-term trend. The stock appears undervalued compared to the industry and the broader market, with a strong Value Score. Analysts project significant growth in earnings and revenues, and the company demonstrates effective capital utilization and a strong liquidity position, making it an attractive investment opportunity.
Vanguard disaggregates reporting for Globe Life (NYSE: GL) after internal realignment
The Vanguard Group has filed an amended Schedule 13G/A for Globe Life Inc. (NYSE: GL), reporting zero beneficial ownership due to an internal realignment effective January 12, 2026. This administrative change means certain Vanguard subsidiaries will now report their holdings separately, in accordance with SEC Release No. 34-39538. The filing clarifies that this reflects a reporting allocation rather than a change in economic exposure or a divestment of Globe Life shares by Vanguard.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Globe Life Inc. (GL) And Encourages Investors to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. (NYSE: GL) securities who bought prior to May 8, 2019, and still hold them. The investigation focuses on whether Globe Life and its officers/directors engaged in corporate wrongdoing. Investors are encouraged to contact the firm for more information and to assist with the investigation, with no cost to them as the firm operates on a contingency fee basis.
GL: Keefe, Bruyette & Woods Reinstates Globe Life with Outperfor
Keefe, Bruyette & Woods has reinstated coverage of Globe Life (GL) with an "Outperform" rating and a price target of $168.00 USD, led by analyst Ryan Krueger. This follows several other analysts who recently raised their price targets for Globe Life. The average target price from 12 analysts is $170.08, indicating a potential upside of 23.43% from the current price.
Globe Life (NYSE:GL) Given Outperform Rating at Keefe, Bruyette & Woods
Keefe, Bruyette & Woods has reiterated an "outperform" rating for Globe Life (NYSE:GL) with a $168 price target, indicating a potential 21.9% upside. While the company missed recent quarterly earnings and revenue estimates, it demonstrated strong margins and provided solid FY2026 EPS guidance. Insider selling by CMO and CEO was noted, but institutional ownership remains high.
Will New US$100 Million Buyback Amid Weaker Earnings Change F&G Annuities & Life's (FG) Narrative
F&G Annuities & Life (FG) has announced a new US$100 million share repurchase program despite reporting weaker earnings and book value per share, though revenue exceeded expectations. This article explores how the buyback influences F&G's investment narrative, particularly in light of ongoing margin pressures and a recent collaboration with Voya Financial to expand annuity distribution. Investors are encouraged to assess the interplay between these capital returns, growth initiatives, and the company's long-term performance.
Globe Life Inc. (NYSE:GL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Globe Life Inc. (NYSE:GL) has received a "Moderate Buy" consensus recommendation from eleven brokerages, with an average one-year price target of $171.33. This positive outlook comes despite recent insider selling totaling over $12 million, including shares sold by the CEO. The company recently reported Q4 EPS that missed estimates, but provided optimistic FY 2026 guidance and increased its quarterly dividend.
Globe Life Inc. stock surges on Q4 2025 earnings beat and Vanguard's major stake disclosure
Globe Life Inc. stock rallied sharply on the NYSE after reporting strong Q4 2025 earnings that exceeded expectations, with a 7% premium growth and improved operating margins. The surge was further amplified by Vanguard Group's disclosure of a 12.67% passive ownership stake, signaling institutional confidence. The company also confirmed its 2026 guidance, highlighting its resilience and appeal to investors seeking stable dividend payers in the insurance sector.
Globe Life Inc. stock surges on strong Q4 2025 earnings beat and Vanguard's 12.67% stake disclosure
Globe Life Inc. shares surged over 8% following a strong Q4 2025 earnings beat, with premium and fee income up 7% and operating margins expanding to 28%. The stock received an additional boost from Vanguard Group's disclosure of a 12.67% passive stake, highlighting institutional confidence. This performance underscores Globe Life's appeal to US investors seeking stable dividend payers in the life insurance sector, especially given its resilience to demographic demands and steady interest rates.
Globe Life Inc. stock faces scrutiny amid insurance sector pressures and market volatility
Globe Life Inc. (GL) is under investor scrutiny due to rising claims costs, competitive dynamics, and market volatility affecting the insurance sector. Despite steady policy growth and a strong direct-to-consumer model, the company faces headwinds from higher morbidity rates and potential interest rate shifts. The article highlights GL's resilience as a defensive play, its strong capital position, and its importance for US investors seeking stability in uncertain economic times.
Stewart Information Services (NYSE: STC) outlines 2026 virtual meeting, pay and board votes
Stewart Information Services (NYSE: STC) has scheduled its 2026 virtual annual meeting for May 7, 2026, where stockholders will vote on the election of ten directors, advisory executive compensation, and the ratification of KPMG LLP as independent auditors. The company's 2025 financial performance showed improvement with increased net income and total revenues, despite ongoing challenges in the residential real estate market. The compensation philosophy emphasizes a "pay-for-performance" approach, with a significant portion of executive compensation tied to financial metrics and long-term shareholder value creation.
CEO transition, 2025 results and pay vote at Kemper (NYSE: KMPB) 2026 meeting
Kemper Corporation's 2026 annual meeting proxy statement details proposals for shareholders, including the election of nine directors, an advisory "Say-on-Pay" vote for executive compensation, and the ratification of Deloitte & Touche LLP as independent auditor. The company reported a significant decrease in net income and adjusted consolidated net operating income for 2025 compared to 2024, alongside a CEO transition, where Joseph P. Lacher Jr. departed and C. Thomas Evans Jr. was appointed Interim CEO. Executive compensation for 2025 reflected this challenging environment, with short-term incentive bonuses for continuing named executive officers paid at substantially below-target levels, typically between 77-83% of the target.
Globe Life Inc stock faces pressure amid regulatory scrutiny and sales practice overhaul
Globe Life Inc. (US3765361038) stock is under pressure due to a regulatory investigation by the Texas Department of Insurance into its sales practices, leading to policy suspensions and leadership changes. This scrutiny, which has involved allegations of forged documents and unauthorized enrollments, has impacted the company's revenue, causing its stock to drop. Despite an operational overhaul and strong capital levels, investor concerns remain over potential litigation costs, fines, and the time it will take to restore full sales capacity amidst an intensifying regulatory environment for the insurance sector.
